Skip to main content
. 2018 May;80(2):241–247. doi: 10.18999/nagjms.80.2.241

Table 2.

Comparison of clinical findings between no PPH and PPH patient with dengue

Number of Patients No PPH (n=17) PPH (n=3) P value
Age (years, mean ± SD)* 25.0 ± 3.8 23.7 ± 3.5 0.58
Gestational age at delivery
(weeks, mean ± SD)**
38.2 ± 1.8 38.6 ± 0.4 0.34
Birth weight (g, mean ± SD) * 2961.8 ± 423.0 3216.7 ± 354.7 0.34
Hematocrit (%, median, min-max) 39.0 (29.5 – 42.5) 39.0 (30.0 – 39.7) 0.364
Platelet (×103 cells/μl, median, min-max)** 90.0 (19.0 – 374.0) 40.0 (12.0 – 57.0) 0.001
Elevated liver enzyme (n, %)*** 1 (5.9) 3 (100.0) 0.004
Interval from onset of symptom to diagnosis
(days, mean ± SD)**
4.7 ± 2.4 4.3 ± 1.2 0.86
Interval from onset of symptom to delivery
(days, mean ± SD)**
5.4 ± 2.7 4.3 ± 1.2 0.72
NS1 positive (n, %)*** 16 (94.1) 2 (66.7) 0.28
Secondary infection (n, %) 2 (11.8) 0 (0.0) 0.72
Bleeding manifestation (n, %) 6 (35.2) 1 (5.9) 0.73
Platelet transfusion before delivery (n, %) 3 (17.6) 0 (0.0) 0.60
Platelet transfusion** (n, %) 3 (17.6) 3 (100.0) 0.018
Premature rupture of membranes (n, %) 7 (41.2) 1 (5.9) 0.67
Cesarean section (n, %) 3 (17.6) 1 (5.9) 0.51

Note: The differences were detected using *unpaired t - test, **Mann-Whitney U test, for continuous variables in accordance with normal or non-normal distribution. ***Fisher’s exact test were used for categorical variables.